SFA Therapeutics (Founding)
Funding Details
Awarder
YCombinator
Date Award
June 18, 2021
Vertical
Healthcare,Therapeutics
Company Info
Founding Year
2021
Market
Healthcare
Location
Philadelphia, PA, USA
Coinvestors
YCombinator
Company Description

SFA Therapeutics is creating therapeutically-tailored oral drugs that regulate the immune system from bacterial metabolites; with a focus on autoimmune diseases and cancers that originate from chronic inflammation. There are over 100 million patients who suffer from autoimmune diseases. Our treatment is designed to block the root cause of many of these chronic inflammatory diseases, with a safe oral drug.